StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) stock

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.18−0.01 (-3.02%)

Close on Nov 18, 2026Market cap $2.50MP/E –Yield –

VolitionRx market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

VolitionRx's market cap was $2.45M on Nov 11, 2026, against $35.26M a year earlier. Over the last 5 years it ranged from $2.35M to $167.12M, with a median of $62.24M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.45M-91.2%
2025Dec 31, 2025$28.02M-49.5%
2024Dec 31, 2024$55.44M-1.7%
2023Dec 29, 2023$56.41M-59.6%
2022Dec 30, 2022$139.72M-16.4%
2021Dec 31, 2021$167.12M-10.6%
2020Dec 31, 2020$186.97M-4.0%
2019Dec 31, 2019$194.78M+207.2%
2018Dec 31, 2018$63.41M-18.7%
2017Dec 29, 2017$77.96M-27.7%
2016Dec 30, 2016$107.89M+32.7%
2015Dec 31, 2015$81.32M+45.7%
2014Dec 31, 2014$55.80M+101.0%
2013Dec 31, 2013$27.76M+1.8%
2012Dec 31, 2012$27.27M+153.0%
2011Dec 5, 2011$10.78M–

More VolitionRx figures

See a number that looks wrong?